Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Placebos Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Platinum Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2017

Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer

Voong, K. R., Feliciano, J., Becker, D. & Levy, B. Sep 1 2017 In : Annals of Translational Medicine. 5, 18, 376

Research output: Research - peer-reviewReview article

Non-Small Cell Lung Carcinoma
Immunotherapy
Biomarkers
Neoplasms
Therapeutics

Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort

Foster, J. C., Le-Rademacher, J. G., Feliciano, J. L., Gajra, A., Seisler, D. K., Dematteo, R., Lafky, J. M., Hurria, A., Muss, H. B., Cohen, H. J. & Jatoi, A. 2017 (Accepted/In press) In : Cancer.

Research output: Research - peer-reviewArticle

Nocebo Effect
Neoplasms
Therapeutics
Placebos
Placebo Effect

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

Baggstrom, M. Q., Socinski, M. A., Wang, X. F., Gu, L., Stinchcombe, T. E., Edelman, M. J., Baker, S., Feliciano, J., Novotny, P., Hahn, O., Crawford, J. A. & Vokes, E. E. May 1 2017 In : Journal of Thoracic Oncology. 12, 5, p. 843-849 7 p.

Research output: Research - peer-reviewArticle

Combination Drug Therapy
Platinum
Non-Small Cell Lung Carcinoma
Placebos
Maintenance

Neutrophil-lymphocyte ratio is a prognosticmarker in patients with locally advanced (stage IIIA and IIIB) non-small cell lung cancer treated with combined modality therapy

Scilla, K. A., Bentzen, S. M., Lam, V. K., Mohindra, P., Nichols, E. M., Vyfhuis, M. A., Bhooshan, N., Feigenberg, S. J., Edelman, M. J. & Feliciano, J. L. Jun 1 2017 In : Oncologist. 22, 6, p. 737-742 6 p.

Research output: Research - peer-reviewArticle

Combined Modality Therapy
Non-Small Cell Lung Carcinoma
Neutrophils
Lymphocytes
Survival

Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)

Lam, V. K., Bentzen, S. M., Mohindra, P., Nichols, E. M., Bhooshan, N., Vyfhuis, M., Scilla, K. A., Feigenberg, S. J., Edelman, M. J. & Feliciano, J. L. Feb 1 2017 In : Lung Cancer. 104, p. 52-57 6 p.

Research output: Research - peer-reviewArticle

Non-Small Cell Lung Carcinoma
Obesity
Survival
Body Mass Index
Weights and Measures